X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:

PacBio Sequencing for Allele-Specific HLA Typing to be Showcased at American Society for Histocompatibility and Immunogenetics (ASHI) Annual Meeting

Monday, October 20, 2014

MENLO PARK, Calif., Oct. 20, 2014 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II DNA Sequencing System, today announced that its unique Single Molecule, Real-Time (SMRT®) Sequencing technology will be featured in a number of presentations at the 2014 American Society for Histocompatibility and Immunogenetics (ASHI) 40th Annual Meeting taking place October 20-24 in Denver, CO.

“With industry-leading read lengths, accuracy, and fast turnaround time, the PacBio RS II can sequence full-length HLA gene alleles and reliably provide directly phased HLA types without imputation,” said Kevin Corcoran, Senior Vice President of Market Development for Pacific Biosciences. “We have received a lot of interest over the past year in HLA applications on our platform and are excited to participate in the ASHI conference to showcase our unique solution and discuss emerging immunogenomic research applications.”

Attendees at the meeting can learn more about SMRT Sequencing at the following presentations:

Podium Presentations:

Tuesday, October 21

Session: New & Improved NGS

2:00 p.m. – 3:30 p.m.

  • OR01: Automated Assembly of Complex Immunogenetic Haplotypes Using Long-Read, Single Molecule, Real-Time Sequencing of Fosmids

    Richard J. Hall, Ph.D., Pacific Biosciences, Menlo Park, CA
  • OR05: Complete Resequencing of Extended Genomic Regions Using Fosmid Target Capture and Single Molecule Real-Time (SMRT®) Long Read Sequencing Technology

    Daniel Geraghty, Ph.D., Fred Hutchinson Cancer Research Center, Seattle, WA

Thursday, October 23

Session: Scholar Awards

2:00 p.m. – 3:30 p.m.

  • OR59: Generation of 252 HLA Class I Genomic Sequences in a Single Sequencing Reaction Using DNA Barcodes and Single Molecule Real-Time (SMRT) DNA Sequencing Technology

    Dr. Neema P. Mayor, Anthony Nolan, London, United Kingdom; UCL Cancer Institute, London, United Kingdom

Workshop:

Wednesday, October 22

12:00 p.m. – 2:00 p.m.

“Advances in Fully Phased HLA & KIR Typing Using SMRT® Sequencing”

  • The Challenge of HLA Diversity in 2014

    Prof. Steve Marsh, Anthony Nolan Research Institute & University College London

  • Clinical HLA Typing on PacBio Platform

    Nezih Cereb, M.D., President & CEO, Histogenetics
  • KIR Haplotypes: The Long and Short of It

    Martin Maiers, Ph.D., Director, Bioinformatics Research, National Bone Marrow Donor Program

Posters:  

  • LBP04: Application of Single Molecule Real-Time (SMRT) Sequencing Technology for the Field 4 Level Genotyping of Classical HLA Loci

  • LBP07: Evaluation of Multiplexing Strategies for HLA Genotyping Using PacBio Sequencing Technologies

Attendees can also visit members of the PacBio staff at booth #307. For more information or to register for the PacBio workshop visit: https://go.pardot.com/l/1652/2014-08-22/2wst89.

About the PacBio RS II and SMRT Sequencing

Pacific Biosciences’ SMRT Sequencing technology achieves the industry’s longest read lengths, highest consensus accuracy, and the least degree of bias. These characteristics, combined with the ability to detect many types of DNA base modifications (e.g., methylation) as part of the sequencing process, make the PacBio RS II an essential tool for many scientists studying genetic and genomic variation. The PacBio platform provides a sequencing solution that can address a growing number of complex medical, agricultural, and industrial problems.

About Pacific Biosciences

Pacific Biosciences of California, Inc. (Nasdaq:PACB) offers the PacBio RS II DNA Sequencing System to help scientists solve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT) technology, the company’s products enable: targeted sequencing to more comprehensively characterize genetic variations; de novo genome assembly to more fully identify, annotate, and decipher genomic structures; and DNA base modification identification to help characterize epigenetic regulation and DNA damage. By providing access to information that was previously inaccessible, Pacific Biosciences enables scientists to increase their understanding of biological systems. More information is available at www.pacb.com

CONTACT: For Pacific Biosciences:

         Media:

         Nicole Litchfield

         415.793.6468

         nicole@bioscribe.com



         Investors:

         Trevin Rard

         650.521.8450

         ir@pacificbiosciences.com

Source: Pacific Biosciences of California, Inc.

News Provided by Acquire Media

Press Release

Pacific Biosciences Announces New Chief Financial Officer

Monday, September 14, 2020

Stay
Current

Visit our blog »